ZTS
Zoetis Inc.
Zoetis (ZTS) Q2 2026 earnings
Published Aug 6, 2026
AI summary
- Revenue $2.47B, down 0.2% from $2.47B a year ago.
- Adjusted EPS $1.87 beat the $1.85 consensus by $0.02, up from $1.78 a year ago.
- Zoetis reported second quarter revenue of $2.5 billion, which was flat compared to the same period last year.
- Net income for the quarter was $691 million, or $1.65 per diluted share.
- U.S. revenue declined 7% due to softer demand in companion animal products and increased competition.
Results vs analyst consensus
Revenue
Reported
$2.47B
Consensus not captured before release
−0.2% YoY
Adjusted EPS
Reported · Adjusted Diluted EPS
$1.87
Consensus $1.85
Beat by $0.02GAAP EPS: $1.65
Consensus: Yahoo Finance · Q2 2026 · EPS estimate at release
Revenue display rounded; difference uses exact result.
Next quarter outlook
$9.12B–$9.32B
Full Year 2026 revenue guidance
Next-quarter consensus not captured before release.
What to watch
- Companion animal market demand is pressured by lower clinic visits and pet owner price sensitivity.
- Key dermatology and pain products faced heightened competitive pressure and generic competition.
Read original report
Source: Zoetis Inc. press release · SEC Form 8-K exhibit 99.1